Succinylcholine Chloride Injection — Class II drug recall D-0623-2025
Ongoing recall by Zydus Pharmaceuticals (USA) Inc, reported 2025-09-17, distributed in LA, MS, OH, PR. Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual un
| Recall number | D-0623-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Zydus Pharmaceuticals (USA) Inc, Pennington, NJ, United States |
| Recall initiated | 2025-08-27 |
| Classified | 2025-09-08 |
| Reported by FDA | 2025-09-17 |
| Distributed | LA, MS, OH, PR |
| Quantity | 270,125 vials |
| Reason classes | specification failure |
| NDC | 70710-1377, 70710-1377-01, 70710-1377-02 |
| Lot numbers | L400077, L400113, L400372, L400373, L400374 |
| Expiration dates | 2025-08-31, 2025-09-30, 2026-03-31, 2026-04-30 |
Product
Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL), Rx only, 10 mL Multiple-dose Vial, Sterile, Manufactured by Zydus Lifesciences Ltd, Vadodara, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1377-1 (vial), NDC 70710-1377-2 (carton).
Reason for recall
Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0623-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.